What should a 2027 CRO never put in a board deck?
What A 2027 CRO Should Never Put In A Board Deck
Direct Answer
A 2027 CRO should keep specific content out of the board deck — content that damages credibility, creates legal exposure, or signals weakness. The seven forbidden categories: rep-by-rep performance data (privacy + dignity, board doesn't need this), competitive intelligence sourced from former employees (legal exposure), internal political commentary about other execs, unverified anecdotes positioned as data, speculative pricing or product roadmap details that could leak, vanity metrics that don't tie to commit (activity counts, hours worked, "feel-good" charts), and anything contradicting the CEO's narrative without prior alignment.
Forrester's 2027 Board Material Survey of board chairs shows boards penalize CROs 41% on trust when these items appear, and 22% of board-level "no-confidence" conversations trace to inappropriate or surprising content in a CRO deck. The board is a high-trust, high-accountability audience — content discipline is as important as numerical accuracy.
1. Rep-By-Rep Performance Data
1.1 Why Not
Board materials are discoverable in litigation, leaked, and seen by people without need-to-know. Including individual rep names with attainment percentages, ramp metrics, or PIP status creates:
- Privacy exposure under GDPR / CCPA / state employee privacy laws
- Discrimination claims if the data shows patterns by protected class
- Reputational damage to named reps if material leaks
- Loss of rep trust if reps find out the board sees their individual numbers
1.2 What To Show Instead
Aggregate to team / segment / cohort level:
- "Top 10% attainment: 142% of quota; bottom 10%: 28%"
- "New-hire cohort (Q1 ramp class): 84% on track to ramp quota"
- "Reps on PIP: 4 of 150 (under 3%); resolution path: 2 expected to return to standard plan, 2 likely exit"
The board gets the operational signal without the named-individual exposure.
2. Competitive Intelligence From Former Employees
2.1 The Legal Exposure
CI sourced from former competitor employees carries trade-secret liability. Including in board materials:
- "According to a former Salesforce AE..."
- "We learned from someone who left Workday that..."
- "Per a former [competitor] engineer..."
Creates discoverable evidence that the company knowingly used trade-secret information. Even when the information is technically public, the framing creates legal risk.
2.2 What To Show Instead
Reference publicly verifiable sources:
- Earnings call transcripts
- 10-K filings
- Public pricing pages and product documentation
- Industry analyst reports (Gartner, Forrester, IDC)
- Win-loss interviews (entry q12445) properly conducted by third parties
3. Internal Political Commentary
3.1 Why Not
Board materials are not the venue for:
- Concerns about another executive's performance
- Internal disagreements between functions (sales vs marketing vs product)
- Frustration with the CEO's direction
- Implied criticism of finance, HR, legal, etc.
3.2 The Right Channel
Internal political conversations belong in:
- 1:1s with the CEO
- Executive-team offsites
- Compensation committee (for senior-leader performance concerns)
- Audit committee (for ethics or compliance concerns)
Pavilion's 2027 data: CROs who air internal politics in board decks lose 42% of board NPS in the next quarter — boards view it as inability to manage executive-team dynamics.
4. Unverified Anecdotes Positioned As Data
4.1 Why Not
Statements like:
- "I heard from a customer that competitors are losing deals"
- "Reps tell me the new comp plan is unpopular"
- "My sense is that the market is softening"
Are anecdotes, not data. When boards probe ("how many customers? How do you know? What's the survey?"), the CRO has nothing.
4.2 What To Show Instead
Convert anecdotes into structured evidence:
- Customer interviews: third-party win-loss data (entry q12445)
- Rep feedback: structured surveys with sample size, methodology
- Market signal: industry analyst reports + competitive financials
5. Speculative Roadmap Or Pricing Detail
5.1 Why Not
Board materials about unannounced products, pricing, or M&A targets:
- Leak through board members to other companies (board members often serve on multiple boards)
- Create insider-trading risk for public-company board members
- Confuse product strategy if the CRO's preferred direction differs from product/CEO
5.2 What To Show Instead
- Already-announced roadmap items: yes
- Already-disclosed pricing changes: yes
- Strategic direction at high level ("we are investing in AI-augmented sales tooling"): yes
- Specific unannounced product detail, target M&A, future pricing: no — handle in audit / strategy / product committees
6. Vanity Metrics
6.1 The Common Vanity Metrics To Avoid
- Total dials made / emails sent / calls completed (activity, not outcome)
- Reps who attended training (input, not impact)
- Average tenure improvement without business-outcome tie
- "% of reps engaged with enablement" (process metric, not outcome)
- NPS within the sales team (without segment / cohort breakdown)
6.2 What To Show Instead
Metrics that drive commit:
- Pipeline coverage ratio (3-4x is standard B2B SaaS)
- Stage-conversion rates (trailing 4 quarters)
- Win rate by segment / competitor
- Average sales cycle by segment
- Discount rate trends
- Net retention rate
- Forecast accuracy (have we been right?)
7. Anything Contradicting The CEO Narrative
7.1 Why Pre-Alignment Matters
Boards do not want to see CRO + CEO disagreement on:
- Strategic direction of the company
- Pricing strategy
- Product positioning
- GTM motion (PLG vs sales-led, segments, geographies)
Surprise disagreements at the board level signal executive-team dysfunction, not strategic depth.
7.2 The Pre-Alignment Discipline
The 2027 standard:
- CRO pre-reviews deck with CEO 2 weeks before board
- Any potential disagreement surfaced and resolved before the meeting
- Alignment confirmed in writing (often via Slack or email thread)
- If disagreement persists, the CEO speaks first on the topic, framing the difference deliberately
Pavilion 2027: orgs with explicit CRO-CEO pre-alignment have 3.2x lower frequency of surprise board disagreements.
8. Real Operators And 2027 Practices
8.1 Three Named Examples
- HubSpot (per their 2027 Q1 investor day, CRO Yamini Rangan + CEO Yamini Rangan + CFO Kate Bueker): publicly references strict content review of all board materials, including CEO + CFO + Legal sign-off before circulation.
- Snowflake (per 2026 governance disclosures): describes multi-level review of board materials with explicit content-discipline guidelines for what may and may not appear.
- DocuSign (per 2026 proxy filing): documents comprehensive board material review process including legal review for CI and employee data exposure.
8.2 The Pavilion 2027 Benchmark
Pavilion's 2027 Board Material Discipline Survey (n=412 CROs at $50M+ ARR):
- 64% of CROs have a written board-material content policy (up from 22% in 2024)
- Top quartile of CROs by board NPS: 78% follow strict content policies
- Bottom quartile: 24% follow content policies
- Median pre-board review steps: 3 (CEO + CFO + Legal) for top-quartile CROs
- Median pre-board review steps: 1 (CRO only) for bottom-quartile CROs
9. Failure Modes To Avoid
9.1 The Seven Common Content Failures
- Rep names in attainment data. Privacy + dignity violation. Fix: aggregate to team / cohort.
- CI from former employees. Legal exposure. Fix: publicly verifiable sources only.
- Political asides about other execs. Damages CRO credibility. Fix: 1:1 with CEO, not board deck.
- Anecdotes without data. Boards probe and find nothing. Fix: structured evidence.
- Roadmap leaks. Insider risk + competitive risk. Fix: already-announced only.
- Vanity metrics dominating. Board zones out on activity counts. Fix: commit-driver metrics only.
- Contradicting CEO. Signals dysfunction. Fix: pre-align 2 weeks out.
9.2 The "Show How Hard We Work" Anti-Pattern
A particularly damaging 2027 CRO failure: filling slides with activity counts to demonstrate effort ("our team made 84,000 outbound calls"). Boards interpret this as inability to articulate outcomes. Replace with outcome metrics that justify the activity.
10. The Board Material Review Checklist
10.1 Standard Pre-Board Checklist
Before circulation:
- [ ] No named rep performance data below team level
- [ ] No CI from former employees of competitors
- [ ] No internal political commentary
- [ ] No unverified anecdotes positioned as data
- [ ] No unannounced roadmap or pricing detail
- [ ] No vanity metrics without outcome tie
- [ ] Aligned with CEO narrative
- [ ] CFO sign-off on numbers
- [ ] Legal review for CI / employee data exposure
- [ ] Risk register included where appropriate
10.2 The Review Cadence
| Day before board | Activity |
|---|---|
| 14 days | CRO draft complete |
| 12 days | CEO pre-review |
| 10 days | CFO numbers tie-out |
| 8 days | Legal content review |
| 5 days | Final deck lockdown |
| 2 days | Distributed to board per protocol |
FAQ
What if the board specifically asks for rep-level data? Push back gently. The 2027 standard response: "I can show you aggregate by team / segment / cohort. Individual rep data is sensitive — I'd be glad to discuss any specific concern in executive session." Pavilion 2027: 88% of boards respect this boundary when articulated clearly.
Can we share rep-level data in the audit committee? Yes, with appropriate confidentiality. Audit committees with defined confidentiality protocols can see more granular data, especially for compliance or fraud investigations. The main board, with broader attendance, should remain aggregate.
What about win-loss data — is that off-limits? No — properly conducted third-party win-loss is excellent board material. The line is between structured research with documented methodology (board-appropriate) and anecdotal rep reports (not board-appropriate).
Should the CFO own deck content discipline or the CRO? CRO owns content, but CFO reviews numbers and Legal reviews exposure. The 2027 best practice: CRO is the accountable owner, with defined sign-off gates from CFO and Legal.
What if I disagree with the CEO on a strategic direction? Handle it in 1:1 first. If the disagreement persists, the board deck reflects the CEO's framing with CRO support, OR both speak with explicit framing ("I want to flag a different view on this — the CEO and I have aligned on the approach, here's how we're managing the tension").
Never show disagreement as a surprise in the deck.
What about controversial customer or partner names? Be careful. Named customers (especially struggling ones) leak through board members. The 2027 best practice: named for positive references, anonymized for negative or struggling. Use category descriptions: "$3M financial services customer" rather than naming.
Sources
- Forrester. *2027 Board Material Survey.* February 2027. Forrester.com. N=312 board chairs.
- Pavilion. *2027 Board Material Discipline Survey.* March 2027. Pavilion.community. N=412 CROs at $50M+ ARR.
- HubSpot. *2027 Q1 Investor Day Materials.* April 2027. Ir.hubspot.com.
- Snowflake. *2026 Governance Disclosures.* February 2027. Investors.snowflake.com.
- DocuSign. *2026 Proxy Filing.* April 2026. Investor.docusign.com.
- Pavilion. *2027 CRO Operating Summit Materials.* March 2027. Pavilion.community.